| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1999;100:608-613.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
Age-Dependent Association of Apolipoprotein E Genotype With Coronary and Aortic Atherosclerosis in Middle-Aged Men
An Autopsy Study
From the Medical School, University of Tampere, and Tampere University Hospital (E.I., T.L., P.J.K.); the Department of Human Molecular Genetics, National Public Health Institute, Helsinki (M.P.); the Department of Clinical Chemistry, Tampere University Hospital, and the Laboratory of Atherosclerosis Genetics, Tampere (E.I., T.L., T.K.); the Tampere School of Public Health, University of Tampere, and Tampere University Hospital (P.L.); and the Department of Forensic Medicine, University of Helsinki (V.S., J.P., A.P., K.H.L., A.M., K.K.L.), Finland.
Correspondence to Erkki Ilveskoski, MD, Medical School, University of Tampere, PO Box 607, FIN-33101, Tampere, Finland. E-mail ei46478{at}uta.fi
Background—Apolipoprotein E
(apoE) polymorphism is one of the genetic determinants of serum
cholesterol values. The apoE 
4 allele has been
associated with advanced coronary heart disease (CHD) diagnosed
by angiography, but the role of the apoE genotype in
atherosclerosis has not been confirmed at vessel-wall
level, nor is any age-dependent effect of the apoE genotype on
the development of CHD known.
Methods and Results—The right and left anterior descending
coronary arteries (RCA and LAD) and the aorta from 700 male
autopsy cases (Helsinki Sudden Death Study) in 1981-1982 and 1991-1992
(average age 53 years, range 33 to 70 years) were stained for fat, and
all areas covered with fatty streaks, fibrotic plaques, and complicated
lesions were measured. In the RCA and LAD, the apoE genotype
was significantly associated with the area of total atherosclerotic
lesions in men <53 years old but not with that in older men
(P=0.0085 and P=0.041, respectively, for
age-by-genotype interaction). Men <53 years old with the
4/3 genotype showed 61% larger total atherosclerotic lesion
area in the RCA (P=0.0027) and 26% larger area in the
LAD (P=0.12) than did men with the 3/3. The apoE
4/3 was also associated with atherosclerotic lesions in the
abdominal (P=0.014) and thoracic (P=0.12)
aorta, but this effect, unlike that of the coronary arteries,
was not age-related.
Conclusions—In men, the apoE 4 allele is a significant
genetic risk factor for coronary
atherosclerosis in early middle age. This suggests that
at older age, other known risk factors of CHD play a more important
role in the atherosclerotic process than apoE polymorphisms.
Key Words: apolipoproteins • atherosclerosis • coronary disease
This article has been cited by other articles:
 |
|
 |
|
  J. Guan, H.-L. Zhao, L. Baum, Y. Sui, L. He, H. Wong, F. M. M. Lai, P. C. Y. Tong, and J. C. N. Chan Apolipoprotein E polymorphism and expression in type 2 diabetic patients with nephropathy: clinicopathological correlation Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1889 - 1895. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Viiri, K. M. Viiri, E. Ilveskoski, H. Huhtala, M. Maki, P. J. Tienari, M. Perola, T. Lehtimaki, and P. J. Karhunen Interactions of Functional Apolipoprotein E Gene Promoter Polymorphisms With Smoking on Aortic Atherosclerosis Circ Cardiovasc Genet, December 1, 2008; 1(2): 107 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Hogue, R. Fucetola, T. Hershey, K. Freedland, V. G. Davila-Roman, A. M. Goate, and R. E. Thompson Risk Factors for Neurocognitive Dysfunction After Cardiac Surgery in Postmenopausal Women Ann. Thorac. Surg., August 1, 2008; 86(2): 511 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kockx, W. Jessup, and L. Kritharides Regulation of Endogenous Apolipoprotein E Secretion by Macrophages Arterioscler Thromb Vasc Biol, June 1, 2008; 28(6): 1060 - 1067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kristiansson, E. Ilveskoski, T. Lehtimaki, L. Peltonen, M. Perola, and P. J. Karhunen Association Analysis of Allelic Variants of USF1 in Coronary Atherosclerosis Arterioscler Thromb Vasc Biol, May 1, 2008; 28(5): 983 - 989. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Karhunen, H. Forss, S. Goebeler, H. Huhtala, E. Ilveskoski, O. Kajander, J. Mikkelsson, A. Penttila, M. Perola, H. Ranta, et al. Radiographic Assessment of Dental Health in Middle-aged Men Following Sudden Cardiac Death Journal of Dental Research, January 1, 2006; 85(1): 89 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Kolovou, K. K. Anagnostopoulou, D. P. Mikhailidis, D. B. Panagiotakos, N. D. Pilatis, M. A. Cariolou, N. Yiannakouris, D. Degiannis, G. Stavridis, and D. V. Cokkinos Association of Apolipoprotein E Genotype with Early Onset of Coronary Heart Disease in Greek Men Angiology, November 1, 2005; 56(6): 663 - 670. [Abstract] [PDF]
|
|
|
|
 |
|
 F A Sayed-Tabatabaei, A F C Schut, A Arias Vasquez, A M Bertoli-Avella, A Hofman, J C M Witteman, and C M van Duijn Angiotensin converting enzyme gene polymorphism and cardiovascular morbidity and mortality: the Rotterdam Study J. Med. Genet., January 1, 2005; 42(1): 26 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pertovaara, T. Lehtimaki, R. Rontu, J. Antonen, A. Pasternack, and M. Hurme Presence of apolipoprotein E {epsilon}4 allele predisposes to early onset of primary Sjogren's syndrome Rheumatology, December 1, 2004; 43(12): 1484 - 1487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Seo, T. Wang, H. Dressman, E. E. Herderick, E. S. Iversen, C. Dong, K. Vata, C. A. Milano, F. Rigat, J. Pittman, et al. Gene Expression Phenotypes of Atherosclerosis Arterioscler Thromb Vasc Biol, October 1, 2004; 24(10): 1922 - 1927. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Gottlieb, A. L. DeStefano, D. J. Foley, E. Mignot, S. Redline, R. J. Givelber, and T. Young APOE {epsilon}4 is associated with obstructive sleep apnea/hypopnea: The Sleep Heart Health Study Neurology, August 24, 2004; 63(4): 664 - 668. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Song, M. J. Stampfer, and S. Liu Meta-Analysis: Apolipoprotein E Genotypes and Risk for Coronary Heart Disease Ann Intern Med, July 20, 2004; 141(2): 137 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Grunenfelder, M. Umbehr, A. Plass, L. Bestmann, F. E. Maly, G. Zund, and M. Turina Genetic polymorphisms of apolipoprotein E4 and tumor necrosis factor {beta} as predisposing factors for increased inflammatory cytokines after cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., July 1, 2004; 128(1): 92 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.J. C. Slooter, M. Cruts, A. Hofman, P. J. Koudstaal, D. van der Kuip, M.A. J. de Ridder, J.C. M. Witteman, M.M. B. Breteler, C. Van Broeckhoven, and C. M. van Duijn The impact of APOE on myocardial infarction, stroke, and dementia: The Rotterdam Study Neurology, April 13, 2004; 62(7): 1196 - 1198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Roher, C. Esh, T. A. Kokjohn, W. Kalback, D. C. Luehrs, J. D. Seward, L. I. Sue, and T. G. Beach Circle of Willis Atherosclerosis Is a Risk Factor for Sporadic Alzheimer's Disease Arterioscler Thromb Vasc Biol, November 1, 2003; 23(11): 2055 - 2062. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Kolovou, D. Daskalova, and D. P. Mikhailidis Apolipoprotein E Polymorphism and Atherosclerosis Angiology, January 1, 2003; 54(1): 59 - 71. [Abstract] [PDF]
|
|
|
|
 |
|
 T. Lehtimaki, P. Dastidar, H. Jokela, T. Koivula, S. Lehtinen, C. Ehnholm, and R. Punnonen Effect of Long-Term Hormone Replacement Therapy on Atherosclerosis Progression in Postmenopausal Women Relates to Functional Apolipoprotein E Genotype J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4147 - 4153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Eichner, S. T. Dunn, G. Perveen, D. M. Thompson, K. E. Stewart, and B. C. Stroehla Apolipoprotein E Polymorphism and Cardiovascular Disease: A HuGE Review Am. J. Epidemiol., March 15, 2002; 155(6): 487 - 495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Rask-Nissila, E. Jokinen, J. Viikari, A. Tammi, T. Ronnemaa, J. Marniemi, P. Salo, T. Routi, H. Helenius, I. Valimaki, et al. Impact of Dietary Intervention, Sex, and Apolipoprotein E Phenotype on Tracking of Serum Lipids and Apolipoproteins in 1- to 5-Year-Old Children: The Special Turku Coronary Risk Factor Intervention Project (STRIP) Arterioscler Thromb Vasc Biol, March 1, 2002; 22(3): 492 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. A. Kajander, P. J. Karhunen, and H. T. Jacobs The relationship between somatic mtDNA rearrangements, human heart disease and aging Hum. Mol. Genet., February 1, 2002; 11(3): 317 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Pollanen, P. J. Karhunen, J. Mikkelsson, P. Laippala, M. Perola, A. Penttila, K. M. Mattila, T. Koivula, and T. Lehtimaki Coronary Artery Complicated Lesion Area Is Related to Functional Polymorphism of Matrix Metalloproteinase 9 Gene: An Autopsy Study Arterioscler Thromb Vasc Biol, September 1, 2001; 21(9): 1446 - 1450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Newman, D. T. Laskowitz, W. D. White, J. L. Kirchner, H. P. Grocott, M. Stafford-Smith, M. H. Sketch, R. H. Jones, J. G. Reves, and A. M. Saunders Apolipoprotein E Polymorphisms and Age at First Coronary Artery Bypass Graft Anesth. Analg., April 1, 2001; 92(4): 824 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Batalla, R. Alvarez, S. Hevia, J. R. Reguero, and E. Coto Apolipoprotein E genotype and coronary heart disease J. Am. Coll. Cardiol., January 1, 2001; 37(1): 329 - 330. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Batalla, R. Alvarez, J. R. Reguero, S. Hevia, G. Iglesias-Cubero, V. Alvarez, A. Cortina, P. Gonzalez, M. M. Celada, A. Medina, et al. Synergistic Effect between Apolipoprotein E and Angiotensinogen Gene Polymorphisms in the Risk for Early Myocardial Infarction Clin. Chem., December 1, 2000; 46(12): 1910 - 1915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Newman, T. O. Stanley, and H. P. Grocott Strategies to Protect the Brain During Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 2000; 4(2): 53 - 64. [Abstract] [PDF]
|
|